
Medically Reviewed by Dr. Mannan Gupta On Oct 27, 2026
This image is AI-generated and intended for illustrative purposes only.
If you’ve been through one or more unsuccessful embryo transfers, you may have heard about the ERA test, or Endometrial Receptivity Analysis, and wondered whether it could explain why implantation did not happen.
I’m Dr. Mannan Gupta, IVF Specialist at Dr. Mannan IVF Centre in New Delhi, and I want to explain where ERA may fit into an IVF evaluation, what it costs, and why it is not a routine test for every patient.
Key Takeaways
The ERA test is a biopsy-based test that analyses gene-expression patterns in the endometrium, or uterine lining, to assess whether it appears receptive at a particular point in the treatment cycle.
The idea behind the test comes from the concept of the window of implantation. This refers to a period when the endometrium has the biological characteristics needed for an embryo to attach.
During an ERA evaluation, a small sample of endometrial tissue is collected at a planned time in a mock or preparation cycle. The tissue is then analysed for patterns of gene activity.
The result may classify the lining as receptive, pre-receptive or post-receptive, depending on the test methodology.
The proposed use is to adjust the timing of a later embryo transfer if the result suggests that the endometrium is receptive earlier or later than expected.
However, I want to make one point clear: ERA does not test the embryo itself, and it cannot tell us whether an embryo will result in a pregnancy.
ERA is considered because transfer timing is one possible factor in implantation, but it is only one part of a much larger picture.
When an embryo transfer doesn’t result in pregnancy, it can be tempting to look for one hidden problem. In reality, implantation depends on several factors, including:
For someone who has experienced repeated implantation failure, a fertility specialist may therefore review the entire cycle rather than immediately ordering one particular test.
Current ASRM guidance specifically states that routine endometrial receptivity panels are not currently recommended, while ESHRE also concludes that there isn’t enough evidence to recommend routine use of commercially available endometrial receptivity tests.
Experience world-class fertility care with Dr. Mannan Gupta at the Best IVF Centre in Delhi
ERA may be discussed in carefully selected patients with repeated implantation failure after other important causes have been assessed.
The decision should depend on your individual IVF history rather than simply the number of failed cycles.
For example, your specialist may review:
This is important because one failed embryo transfer does not automatically mean your implantation window is abnormal.
I would not recommend assuming that ERA is necessary simply because an IVF cycle has failed. The more useful question is, “What information are we still missing in this particular case?”
Most people starting IVF do not need an ERA test as part of their initial treatment.
If you are having your first IVF cycle and there is no particular history suggesting recurrent implantation problems, routine ERA testing adds another procedure and cost without established evidence that it improves the chance of having a baby.
The same principle applies after a single unsuccessful transfer. A failed transfer can occur for many reasons, including embryo-related factors that have nothing to do with endometrial receptivity.
HFEA, the UK’s fertility treatment regulator, currently rates endometrial receptivity testing red for most fertility patients because moderate- and high-quality evidence does not show a reliable improvement in the chance of having a baby.
ERA involves collecting a small biopsy of the endometrial lining at a specific time during a prepared cycle.
The exact protocol can vary depending on the fertility centre and testing laboratory.
In a typical evaluation, the process involves:
The biopsy is an invasive step, so it shouldn’t be treated as a harmless screening test that everyone needs.
You should also ask your clinic whether the quoted price includes the biopsy, laboratory analysis, consultation, medication and any monitoring required for the preparation cycle.
This is where I believe patients need the clearest and most honest explanation: ERA has not been proven to improve live birth rates when used routinely.
Earlier studies suggested that personalised embryo transfer based on ERA results might improve outcomes in selected patients. However, later studies have produced less encouraging results.
A large randomised trial found that ERA-guided timing did not significantly improve live birth outcomes compared with standard timing in the population studied. ASRM’s 2026 committee opinion also states that there is insufficient evidence to support routine ERA testing in recurrent implantation failure.
ESHRE similarly concludes that evidence is insufficient to recommend routine use of commercially available endometrial receptivity testing.
So, if someone tells you that ERA will definitely improve your IVF success, I would be cautious about that statement.
ERA is a test that may provide additional information in selected situations, not a guarantee of implantation or pregnancy.
The ERA test cost in Delhi is commonly quoted in the range of about ₹35,000 to ₹60,000, but the actual amount depends on the clinic, laboratory and services included.
For example, current published Delhi pricing from one fertility provider lists approximately ₹39,000 to ₹41,000, while other Indian fertility providers quote broader ranges.
Your total expense may depend on whether the package includes:
Because pricing changes between centres and laboratories, I recommend asking for an itemised quotation rather than comparing only the headline ERA price.
It may be discussed after repeated implantation failure, but it should not replace a complete evaluation.
This distinction is important.
ASRM’s 2026 guidance recommends assessing several possible causes in patients with recurrent implantation failure and specifically lists endometrial receptivity panels among tests that are not currently recommended routinely because evidence for improved live birth remains insufficient.
Depending on your history, your doctor may instead review or investigate areas such as:
You can read more about how we assess and correct these uterine cavity issues on our Fertility Enhancing Surgery page.
This broader approach is often more useful than assuming every failed transfer has the same cause.
If you want to understand the possible reasons behind an unsuccessful IVF cycle, I also explain the broader evaluation in Failed IVF Treatment in New Delhi, covering the investigative approach to recurrent implantation failure.
No. Endometrial thickness and endometrial receptivity are different things.
An ultrasound can measure the thickness and appearance of the uterine lining. ERA, on the other hand, analyses gene-expression patterns in an endometrial tissue sample.
A lining can therefore have an apparently acceptable thickness while other factors still need assessment.
This is one reason I don’t recommend judging implantation potential from one measurement alone.
No. A receptive ERA result cannot guarantee implantation or pregnancy.
The test addresses a specific aspect of the endometrium at a particular point in time. Implantation is a complex biological process involving both the embryo and the maternal environment.
Even when an ERA report suggests receptivity, implantation may not occur because of factors that ERA does not assess.
This is also why I don’t advise patients to view ERA as a test that can identify the single reason an IVF cycle failed.
The most important question isn’t “Can I afford the ERA test?” but “Will the result change my treatment in a meaningful way?”
ERA involves a biopsy, laboratory testing and usually an additional treatment cycle or preparation before the result can be applied to embryo transfer.
For some patients, the information may be considered as part of a highly individualised evaluation. For many others, the same money and time may be better directed toward investigating more established causes of implantation failure.
There is no single test that explains every failed IVF transfer.
I prefer to discuss the evidence with patients openly so they can make a decision without feeling that they must add every available IVF test to their treatment.
Assisted reproductive technology services in India are regulated under the Assisted Reproductive Technology (Regulation) Act, 2021. The Act provides for regulation and supervision of ART clinics and ART banks and addresses safe and ethical practice of assisted reproductive technology services.
The Act provides for regulation and supervision of ART clinics and ART banks and addresses safe and ethical practice of assisted reproductive technology services.
If you are considering any specialised fertility investigation or treatment, it is reasonable to ask your clinic about the laboratory involved, what the test includes and how the result will affect your treatment plan.
No. ERA is not a routine test for every IVF patient, and current evidence does not support its routine use.
There is no single number that makes ERA automatically necessary. Your fertility specialist should assess the complete history, embryo factors, uterine cavity and previous treatment before deciding whether it adds useful information.
ERA requires an endometrial biopsy, which can cause cramping or discomfort. Your doctor can explain what to expect and how the procedure will be performed in your particular case.
No. ERA cannot guarantee implantation, pregnancy or a live birth. It assesses one aspect of the endometrium and does not evaluate every factor involved in IVF success.
Usually, one unsuccessful transfer is not enough by itself to conclude that you need an ERA. A broader review of the cycle is generally more appropriate before deciding on additional testing.
No. ERA can assess endometrial gene-expression patterns, but it cannot identify every reason an embryo fails to implant.
No. ERA analyses a sample of the endometrial lining. Tests such as PGT-A, when clinically appropriate, address a different question because they assess embryo chromosomes.
Not necessarily. ERA is often treated as an additional test or add-on, and the biopsy, laboratory analysis, medicines and monitoring may be charged separately. Always ask your clinic for an itemised estimate.
ERA can sound like a precise answer to a difficult IVF problem, especially after repeated implantation failure. But precision in testing does not automatically mean proven clinical benefit.
If you’ve had unsuccessful embryo transfers, I would recommend looking at the complete picture rather than assuming that your implantation window is the problem. Your embryo history, uterine cavity, endometrial preparation, hormonal factors and other relevant findings all deserve consideration.
At Dr. Mannan IVF Centre in New Delhi, my approach is to discuss additional tests based on the individual clinical situation, the available evidence and whether the result is likely to change treatment.
Medical Disclaimer:
This article is for general educational purposes only. It does not replace an individual consultation, physical examination, diagnosis or personalised fertility treatment plan. The suitability of ERA testing depends on your medical history, IVF history and evaluation by a qualified fertility specialist.